Cerebral Antibiotics Distribution After Acute Brain Injury

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Poitiers University Hospital.
Recruitment status was  Recruiting
Information provided by:
Poitiers University Hospital
ClinicalTrials.gov Identifier:
First received: January 29, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted
The aim of the study is to explore the distribution of antibiotics in the brain after an acute brain injury because brain infections treatment is still an health care problem.

Condition Intervention Phase
Bacterial Infection
Brain Injury
Drug: cefotaxime
Drug: Metronidazole
Drug: Ciprofloxacin
Drug: Fosfocine
Phase 1

Study Type: Interventional

Resource links provided by NLM:

Further study details as provided by Poitiers University Hospital:

Arms Assigned Interventions
Experimental: Cefotaxime Drug: cefotaxime
Experimental: Metrodinazole Drug: Metronidazole
Experimental: Ciprofloxacine Drug: Ciprofloxacin
Experimental: Fosfocine Drug: Fosfocine


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Acute brain injury
  • Patient who receive an antibiotic for an infection or prophylaxy
  • Glasgow coma score < 8

Exclusion Criteria:

  • Age < 18 years old
  • Pregnant woman
  • HCV, HIV, HBV infection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01059890

Contact: Claire DAHYOT, MD 05 49 44 44 44 ext 41369 c.dahyot-fizelier@chu-poitiers.fr

Poitiers University Hospital - 2 rue de la Milétrie - Réanimation chirugicale Recruiting
Poitiers, France, 86021
Contact: Claire DAHYOT, MD    05 49 44 44 44 ext 41369    c.dahyot-fizelier@chu-poitiers.fr   
Sponsors and Collaborators
Poitiers University Hospital
  More Information

ClinicalTrials.gov Identifier: NCT01059890     History of Changes
Other Study ID Numbers: A-BRAIN 
Study First Received: January 29, 2010
Last Updated: January 29, 2010
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Additional relevant MeSH terms:
Bacterial Infections
Brain Injuries
Brain Diseases
Central Nervous System Diseases
Craniocerebral Trauma
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Anti-Bacterial Agents
Anti-Infective Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Cytochrome P-450 CYP1A2 Inhibitors
Cytochrome P-450 Enzyme Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Topoisomerase II Inhibitors
Topoisomerase Inhibitors

ClinicalTrials.gov processed this record on May 22, 2016